ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 82 filers reported holding ARATANA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $138,000 | +43.8% | 26,800 | 0.0% | 0.01% | +60.0% |
| Q1 2019 | $96,000 | -61.8% | 26,800 | -34.6% | 0.01% | -64.3% |
| Q4 2018 | $251,000 | -35.1% | 41,000 | -38.1% | 0.01% | -12.5% |
| Q3 2018 | $387,000 | +44.9% | 66,218 | +5.6% | 0.02% | +60.0% |
| Q2 2018 | $267,000 | -49.1% | 62,729 | -47.3% | 0.01% | -44.4% |
| Q1 2018 | $525,000 | -16.1% | 119,100 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $626,000 | -20.1% | 119,100 | -6.8% | 0.02% | -30.8% |
| Q3 2017 | $783,000 | -15.8% | 127,800 | -0.6% | 0.03% | -29.7% |
| Q2 2017 | $930,000 | +212.1% | 128,633 | +209.5% | 0.04% | +85.0% |
| Q4 2016 | $298,000 | -63.1% | 41,563 | -51.9% | 0.02% | -57.4% |
| Q3 2016 | $808,000 | +48.0% | 86,338 | 0.0% | 0.05% | +9.3% |
| Q2 2016 | $546,000 | +112.5% | 86,338 | +85.5% | 0.04% | +168.8% |
| Q1 2016 | $257,000 | +1.6% | 46,538 | +2.6% | 0.02% | -54.3% |
| Q4 2015 | $253,000 | -38.3% | 45,338 | +10.9% | 0.04% | +218.2% |
| Q3 2014 | $410,000 | – | 40,867 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |